Impaired myocellular Ca2+ cycling in protein phosphatase PP2A-B56α KO mice is normalized by β-adrenergic stimulation

Glaser D, Heinick A, Herting JR, Massing F, Müller FU, Pauls P, Rozhdestvensky TS, Schulte JS, Seidl MD, Skryabin BV, Stümpel F, Kirchhefer U.

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

The activity of protein phosphatase 2A (PP2A) is determined by the expression and localization of the regulatory B-subunits. PP2A-B56α is the dominant isoform of the B′-family in the heart. Its role in regulating the cardiac response to β-adrenergic stimulation is not yet fully understood. We therefore generated mice deficient in B56α to test the functional cardiac effects in response to catecholamine administration versus corresponding WT mice. We found the decrease in basal PP2A activity in hearts of KO mice was accompanied by a counter-regulatory increase in the expression of B′ subunits (β and γ) and higher phosphorylation of sarcoplasmic reticulum Ca2+ regulatory and myofilament proteins. The higher phosphorylation levels were associated with enhanced intraventricular pressure and relaxation in catheterized KO mice. In contrast, at the cellular level, we detected depressed Ca2+ transient and sarcomere shortening parameters in KO mice at basal conditions. Consistently, the peak amplitude of the L-type Ca2+ current was reduced and the inactivation kinetics of ICaL were prolonged in KO cardiomyocytes. However, we show β-adrenergic stimulation resulted in a comparable peak amplitude of Ca2+ transients and myocellular contraction between KO and WT cardiomyocytes. Therefore, we propose higher isoprenaline-induced Ca2+ spark frequencies might facilitate the normalized Ca2+ signaling in KO cardiomyocytes. In addition, the application of isoprenaline was associated with unchanged L-type Ca2+ current parameters between both groups. Our data suggest an important influence of PP2A-B56α on the regulation of Ca2+ signaling and contractility in response to β-adrenergic stimulation in the myocardium.

Details zur Publikation

FachzeitschriftJournal of Biological Chemistry (J Biol Chem)
Jahrgang / Bandnr. / Volume298
Ausgabe / Heftnr. / Issue9
StatusVeröffentlicht
Veröffentlichungsjahr2022 (12.09.2022)
Sprache, in der die Publikation verfasst istEnglisch
DOI10.1016/j.jbc.2022.102362
Link zum Volltexthttps://www.sciencedirect.com/science/article/pii/S0021925822008055?via=ihub
StichwörterPP2A-B56α protein phosphorylation myocellular Ca2+ handling LTCC β-adrenergic function

Autor*innen der Universität Münster

Glaser, Dennis
Institut für Pharmakologie und Toxikologie
Heinick, Alexander
Institut für Pharmakologie und Toxikologie
Herting, Julius Roman
Institut für Pharmakologie und Toxikologie
Kirchhefer, Uwe
Institut für Pharmakologie und Toxikologie
Müller, Frank Ulrich
Institut für Pharmakologie und Toxikologie
Pauls, Paul
Institut für Pharmakologie und Toxikologie
Rozhdestvenskiy, Timofey
Fachbereich 05 Medizinische Fakultät (FB05)
Schulte, Jan Sebastian
Institut für Pharmakologie und Toxikologie
Seidl, Matthias
Institut für Pharmakologie und Toxikologie
Skryabin, Boris
Fachbereich 05 Medizinische Fakultät (FB05)
Stümpel, Frank
Institut für Pharmakologie und Toxikologie